BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 20537173)

  • 1. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.
    Gandjbakhch F; Fajardy I; Ferré B; Dubucquoi S; Flipo RM; Roger N; Solau-Gervais E
    J Rheumatol; 2009 May; 36(5):881-6. PubMed ID: 19332633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of the PADI4 gene polymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis].
    Fan LY; Zong M; Lu TB; Yang L; Ding YY; Ma JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):57-61. PubMed ID: 19199253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to 'Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study'.
    Ikari K; Yano K; Yoshida S; Taniguchi A; Yamanaka H; Momohara S
    Arthritis Res Ther; 2014 Aug; 16(5):422. PubMed ID: 25263166
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
    Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
    Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism.
    Tamai M; Kawakami A; Iwamoto N; Arima K; Aoyagi K; Eguchi K
    Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
    Suzuki T; Ikari K; Yano K; Inoue E; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    PLoS One; 2013; 8(4):e61045. PubMed ID: 23577190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
    Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
    Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients.
    Abd-Allah SH; el-Shal AS; Shalaby SM; Pasha HF; Abou el-Saoud AM; el-Najjar AR; el-Shahawy EE
    Joint Bone Spine; 2012 Mar; 79(2):124-8. PubMed ID: 21981985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
    Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
    Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Massarenti L; Enevold C; Damgaard D; Ødum N; Garred P; Frisch M; Shelef MA; Jacobsen S; Nielsen CH
    Front Immunol; 2021; 12():707690. PubMed ID: 34733271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.
    Du Y; Liu X; Guo JP; Liu X; Li R; Zhao Y; Liu X; Li MH; Li ZG
    Clin Exp Rheumatol; 2014; 32(3):377-82. PubMed ID: 24564960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
    Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
    Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.
    Snir O; Gomez-Cabrero D; Montes A; Perez-Pampin E; Gómez-Reino JJ; Seddighzadeh M; Klich KU; Israelsson L; Ding B; Catrina AI; Holmdahl R; Alfredsson L; Klareskog L; Tegnér J; Gonzalez A; Malmström V; Padyukov L
    Arthritis Res Ther; 2014 Aug; 16(4):414. PubMed ID: 25138370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.